{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:28:51Z","timestamp":1787725731291,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05015-6","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:50:36Z","timestamp":1750135836000},"page":"26-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A nomogram model based on CT-assessed body composition parameters for predicting postoperative recurrence in advanced gastric cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Mengying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"5015_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263.","journal-title":"CA Cancer J Clin"},{"key":"5015_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396:635\u2013648.","journal-title":"Lancet"},{"key":"5015_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-024-01773-9","volume":"9","author":"X Chen","year":"2024","unstructured":"Chen X, Xu H, Chen X et al (2024) First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study. Signal Transduct Target Ther 9:73.","journal-title":"Signal Transduct Target Ther"},{"key":"5015_CR4","unstructured":"Ajani JA, D\u2019Amico TA, Almhanna K et al (2019) National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer, Version 1.2019. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/gastric.pdf. Accessed 14 May 2019."},{"key":"5015_CR5","doi-asserted-by":"crossref","unstructured":"Yago A, Haruta S, Ueno M et al (2021) Adequate period of surveillance in each stage for curatively resected gastric cancer: analyzing the time and rates of recurrence [published correction appears in Gastric Cancer. 2021;24(3):762\u2013763.]. Gastric Cancer 24:752\u2013761.","DOI":"10.1007\/s10120-020-01147-4"},{"key":"5015_CR6","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41416-022-02138-1","volume":"128","author":"K Okuno","year":"2023","unstructured":"Okuno K, Watanabe S, Roy S et al (2023) A liquid biopsy signature for predicting early recurrence in patients with gastric cancer. Br J Cancer 128:1105\u20131116.","journal-title":"Br J Cancer"},{"key":"5015_CR7","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1245\/s10434-022-12434-y","volume":"29","author":"G Spolverato","year":"2022","unstructured":"Spolverato G, Capelli G, Mari V et al (2022) Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma. Ann Surg Oncol 29:8653\u20138661.","journal-title":"Ann Surg Oncol"},{"key":"5015_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10120-021-01217-1","volume":"25","author":"JS Bae","year":"2022","unstructured":"Bae JS, Chang W, Kim SH et al (2022) Development of a predictive model for extragastric recurrence after curative resection for early gastric cancer. Gastric Cancer 25:255\u2013264.","journal-title":"Gastric Cancer"},{"key":"5015_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13014-019-1332-y","volume":"14","author":"SB Wang","year":"2019","unstructured":"Wang SB, Qi WX, Chen JY et al (2019) Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy. Radiat Onco 14:128.","journal-title":"Radiat Onco"},{"key":"5015_CR10","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1038\/s41467-022-34703-w","volume":"13","author":"D Chen","year":"2022","unstructured":"Chen D, Fu M, Chi L et al (2022) Prognostic and predictive value of a pathomics signature in gastric cancer. Nat Commun 13:6903.","journal-title":"Nat Commun"},{"key":"5015_CR11","doi-asserted-by":"publisher","first-page":"e171087","DOI":"10.1001\/jamasurg.2017.1087","volume":"152","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Li T, Liang X et al (2017) Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer. JAMA Surg 152:e171087.","journal-title":"JAMA Surg"},{"key":"5015_CR12","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1007\/s00330-021-07697-0","volume":"31","author":"S Liu","year":"2021","unstructured":"Liu S, Qiao X, Ji C et al (2021) Gastric poorly cohesive carcinoma: differentiation from tubular adenocarcinoma using nomograms based on CT findings in the 40 s late arterial phase. Eur Radiol 31:5768\u20135778.","journal-title":"Eur Radiol"},{"key":"5015_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.annonc.2020.04.003","volume":"31","author":"D Dong","year":"2020","unstructured":"Dong D, Fang MJ, Tang L et al (2020) Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol 31:912\u2013920.","journal-title":"Ann Oncol"},{"key":"5015_CR14","first-page":"e340-e350","volume":"4","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang Z, Yuan Q et al (2022) Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study. Lancet Digit Health 4:e340-e350.","journal-title":"Lancet Digit Health"},{"key":"5015_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2019.11.023","volume":"145","author":"W Zhang","year":"2020","unstructured":"Zhang W, Fang M, Dong D et al (2020) Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer. Radiother Onco 145:13\u201320.","journal-title":"Radiother Onco"},{"key":"5015_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/sjg.sjg_253_22","volume":"29","author":"JM Huang","year":"2023","unstructured":"Huang JM, Zhuang LP, Wang HG et al (2023) Radiomics signature for prediction of long-term survival and recurrence patterns in patients with gastric cancer after radical gastrectomy: A multicenter study. Saudi J Gastroenterol 29:21\u201330.","journal-title":"Saudi J Gastroenterol"},{"key":"5015_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","volume":"20","author":"AL Ghaben","year":"2019","unstructured":"Ghaben AL, Scherer PE (2019) Adipogenesis and metabolic health. Nat Rev Mol Cell Biol 20:242\u2013258.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5015_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41577-021-00635-7","volume":"22","author":"WV Trim","year":"2022","unstructured":"Trim WV, Lynch L (2022) Immune and non-immune functions of adipose tissue leukocytes. Nat Rev Immunol 22:371\u2013386.","journal-title":"Nat Rev Immunol"},{"key":"5015_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41574-023-00908-2","volume":"20","author":"RD Jacks","year":"2024","unstructured":"Jacks RD, Lumeng CN (2024) Macrophage and T cell networks in adipose tissue. Nat Rev Endocrinol 20:50\u201361.","journal-title":"Nat Rev Endocrinol"},{"key":"5015_CR20","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/ije\/dyac025","volume":"51","author":"Y Lu","year":"2022","unstructured":"Lu Y, Tang H, Huang P et al (2022) Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study. Int J Epidemiol 51:1204\u20131218.","journal-title":"Int J Epidemiol"},{"key":"5015_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S002966511100320X","volume":"71","author":"SL Doyle","year":"2012","unstructured":"Doyle SL, Donohoe CL, Lysaght J, Reynolds JV (2012) Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc 71:181\u2013189.","journal-title":"Proc Nutr Soc"},{"key":"5015_CR22","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3390\/nu14193971","volume":"14","author":"KE Kim","year":"2022","unstructured":"Kim KE, Bae SU, Jeong WK, Baek SK (2022) Impact of Preoperative Visceral Fat Area Measured by Bioelectrical Impedance Analysis on Clinical and Oncologic Outcomes of Colorectal Cancer. Nutrients 14:3971.","journal-title":"Nutrients"},{"key":"5015_CR23","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.acra.2023.10.057","volume":"31","author":"C Tao","year":"2024","unstructured":"Tao C, Hong W, Yin P et al (2024) Nomogram Based on Body Composition and Prognostic Nutritional Index Predicts Survival After Curative Resection of Gastric Cancer. Acad Radiol 31:1940\u20131949.","journal-title":"Acad Radiol"},{"key":"5015_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1148\/radiol.2018171504","volume":"287","author":"GK Nguyen","year":"2018","unstructured":"Nguyen GK, Mellnick VM, Yim AK, Salter A, Ippolito JE (2018) Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma. Radiology 287:884\u2013892.","journal-title":"Radiology"},{"key":"5015_CR25","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.acra.2023.05.022","volume":"30","author":"S Shi","year":"2023","unstructured":"Shi S, Zhao YX, Fan JL, Chang LY, Yu DX (2023) Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy. Acad Radiol 30:2940\u20132953.","journal-title":"Acad Radiol"},{"key":"5015_CR26","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2337\/db21-0976","volume":"71","author":"L Skudder-Hill","year":"2022","unstructured":"Skudder-Hill L, Sequeira IR, Cho J, Ko J, Poppitt SD, Petrov MS (2022) Fat Distribution Within the Pancreas According to Diabetes Status and Insulin Traits. Diabetes 71:1182\u20131192.","journal-title":"Diabetes"},{"key":"5015_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ebiom.2016.12.004","volume":"15","author":"D Hu","year":"2017","unstructured":"Hu D, Peng F, Lin X et al (2017) Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) Study. EBioMedicine 15:73\u201380.","journal-title":"EBioMedicine"},{"key":"5015_CR28","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1007\/s00330-024-10660-4","volume":"34","author":"J Yoo","year":"2024","unstructured":"Yoo J, Joo I, Jeon SK, Park J, Yoon SH (2024) Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters. Eur Radiol 34:6205\u20136213.","journal-title":"Eur Radiol"},{"key":"5015_CR29","doi-asserted-by":"crossref","unstructured":"Guo Z, Blake GM, Li K et al (2020) Liver Fat Content Measurement with Quantitative CT Validated against MRI Proton Density Fat Fraction: A Prospective Study of 400 Healthy Volunteers [published correction appears in Radiology. 2024;310(3):e249010.]. Radiology 294:89\u201397.","DOI":"10.1148\/radiol.2019190467"},{"key":"5015_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00535-017-1422-2","volume":"53","author":"H Yamazaki","year":"2018","unstructured":"Yamazaki H, Tauchi S, Kimachi M et al (2018) Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study. J Gastroenterol 53:873\u2013882.","journal-title":"J Gastroenterol"},{"key":"5015_CR31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00330-022-08980-4","volume":"33","author":"BB Chen","year":"2023","unstructured":"Chen BB, Liang PC, Shih TT et al (2023) Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma. Eur Radiol 33:512\u2013522.","journal-title":"Eur Radiol"},{"key":"5015_CR32","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1097\/JS9.0000000000001303","volume":"110","author":"H Chen","year":"2024","unstructured":"Chen H, Hu Z, Xu Q et al (2024) The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study. Int J Surg 110:3543\u20133553.","journal-title":"Int J Surg"},{"key":"5015_CR33","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1007\/s00330-022-09345-7","volume":"33","author":"J Wang","year":"2023","unstructured":"Wang J, Dong P, Qu Y et al (2023) Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study. Eur Radiol 33:3232\u20133242.","journal-title":"Eur Radiol"},{"key":"5015_CR34","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1007\/s00330-023-09401-w","volume":"33","author":"M Kim","year":"2023","unstructured":"Kim M, Lee CM, Kang BK, Ha TK, Choi YY, Lee SJ (2023) Sarcopenia assessed with DXA and CT increases the risk of perioperative complications in patients with gastrectomy. Eur Radiol 33:5150\u20135158.","journal-title":"Eur Radiol"},{"key":"5015_CR35","doi-asserted-by":"publisher","first-page":"e222008","DOI":"10.1148\/radiol.222008","volume":"307","author":"M Nachit","year":"2023","unstructured":"Nachit M, Horsmans Y, Summers RM, Leclercq IA, Pickhardt PJ (2023) AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults. Radiology 307:e222008.","journal-title":"Radiology"},{"key":"5015_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jcsm.13404","volume":"15","author":"A Bimurzayeva","year":"2024","unstructured":"Bimurzayeva A, Kim MJ, Ahn JS et al (2024) Three-dimensional body composition parameters using automatic volumetric segmentation allow accurate prediction of colorectal cancer outcomes. J Cachexia Sarcopenia Muscle 15:281\u2013291.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5015_CR37","doi-asserted-by":"crossref","unstructured":"Koo TK, Li MY (2016) A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research [published correction appears in J Chiropr Med. 2017;16(4):346.]. J Chiropr Med 15:155\u2013163.","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"5015_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41467-018-08159-w","volume":"10","author":"AM Barberio","year":"2019","unstructured":"Barberio AM, Alareeki A, Viner B et al (2019) Central body fatness is a stronger predictor of cancer risk than overall body size. Nat Commun 10:383.","journal-title":"Nat Commun"},{"key":"5015_CR39","doi-asserted-by":"publisher","first-page":"e13088","DOI":"10.1111\/obr.13088","volume":"22","author":"EA Silveira","year":"2021","unstructured":"Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C (2021) Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence. Obes Rev 22:e13088.","journal-title":"Obes Rev"},{"key":"5015_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ajg.2014.1","volume":"109","author":"VW Wong","year":"2014","unstructured":"Wong VW, Wong GL, Yeung DK et al (2014) Fatty pancreas, insulin resistance, and \u03b2-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol 109:589\u2013597.","journal-title":"Am J Gastroenterol"},{"key":"5015_CR41","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/biom11071022","volume":"11","author":"CH Tseng","year":"2021","unstructured":"Tseng CH (2021) The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 11:1022.","journal-title":"Biomolecules"},{"key":"5015_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1042\/CS20090399","volume":"118","author":"IF Godsland","year":"2009","unstructured":"Godsland IF (2009) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118:315\u2013332.","journal-title":"Clin Sci (Lond)"},{"key":"5015_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2015.00012","volume":"6","author":"TB Salisbury","year":"2015","unstructured":"Salisbury TB, Tomblin JK (2015) Insulin\/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies. Front Endocrinol (Lausanne) 6:12.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5015_CR44","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","volume":"62","author":"M Bardou","year":"2013","unstructured":"Bardou M, Barkun AN, Martel M (2013) Obesity and colorectal cancer. Gut 62:933\u2013947.","journal-title":"Gut"},{"key":"5015_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0276-9","volume":"35","author":"W Xu","year":"2016","unstructured":"Xu W, Yang Z, Lu N (2016) Molecular targeted therapy for the treatment of gastric cancer. J Exp Clin Cancer Res 35:1.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05015-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05015-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05015-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:04:00Z","timestamp":1769148240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05015-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["5015"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05015-6","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Institutional review board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}